Company news

CareDx, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study

December 12, 2021

CareDx The Transplant Company Surpasses 80,000 Patient Milestone

December 1, 2021

CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500™ for the Third Consecutive Year

November 18, 2021

CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes

November 17, 2021

CareDx To Participate in Upcoming Conferences

November 14, 2021

CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence

November 9, 2021

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices

November 3, 2021

CareDx Focuses on Innovation in Transplant at ASN Kidney Week

November 2, 2021

CareDx Completes Orderly Management Transition

October 31, 2021

CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance

October 27, 2021

CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement

October 18, 2021

CareDx to Report Third Quarter 2021 Financial Results

October 13, 2021

CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication

September 29, 2021

CareDx Names Longtime Patient Advocate Art Torres to Board of Directors

September 14, 2021

CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance

July 28, 2021

CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients

July 25, 2021

CareDx Appoints Dr. Hannah Valantine to its Board of Directors

June 29, 2021

CareDx To Acquire Transplant Hero Medication Management Application

June 7, 2021

CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Survival and Reduction in Biopsies through ARTS Surveillance

June 6, 2021

CareDx Presents Groundbreaking AlloSure® Data at the 2021 American Transplant Congress

June 3, 2021

CareDx Starts Enrollment in MAPLE, a Multi-modal, Multi-center, Prospective Study of LiverCare

May 31, 2021

CareDx Announces Strategic Minority Investment in Miromatrix

May 27, 2021

CareDx Reports First Quarter 2021 Results

May 4, 2021

CareDx to Report First Quarter 2021 Financial Results

April 20, 2021

CareDx Announces New HLA Typing Service Offering for Research Purposes

April 7, 2021

CareDx Enhances Leadership Team with Key Appointments

March 30, 2021

CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular

March 16, 2021

CareDx Names Ankur Dhingra as New Chief Financial Officer

March 10, 2021

CareDx Expands into the Pre-Transplant Kidney Space through TX Connect

February 24, 2021

CareDx Reports Fourth Quarter and Full Year 2020 Results

February 23, 2021

CareDx to Report Fourth Quarter and Full Year 2020 Financial Results

February 11, 2021

CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

February 10, 2021

CareDx Announces Closing of Public Offering of Common Stock

January 24, 2021

CareDx Announces Pricing of Public Offering of Common Stock

January 19, 2021

CareDx Announces Proposed Public Offering of Common Stock

January 18, 2021

CareDx Reports Preliminary Fourth Quarter and Full Year 2020 Results

January 10, 2021

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers

January 7, 2021

CareDx Announces AlloID and Exclusive Partnership with IDbyDNA

January 6, 2021

CareDx’s AlloSeq HCT Wins Tender for French Stem Cell Transplant Patient Surveillance

January 3, 2021

CareDx Announces First AlloSure Pediatrics Publication

November 30, 2020

CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart

November 16, 2020

CareDx Joins National Kidney Foundation in Virtual Walk for Kidney Patients

November 5, 2020

Peter Maag Appointed Executive Chairman of the Board of Directors of CareDx; Reginald Seeto Appointed President and CEO

October 28, 2020

CareDx to Report Third Quarter 2020 Financial Results

October 14, 2020

CareDx Reports Preliminary Third Quarter 2020 Revenue

October 6, 2020

CareDx Announces Publication of Pivotal AlloSure Lung Data

October 1, 2020

CareDx Receives Final Medicare Coverage Decision for AlloSure Heart

September 30, 2020

CareDx Launches AlloCare at Virtual Transplant Festival

September 23, 2020

CareDx Strengthens Leadership Team to Accelerate Growth

September 9, 2020

CareDx Reports Second Quarter 2020 Results

August 3, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 23 decks. Every deck is listed under its year.